This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955756.

First In-Pharma-tion training held

Following the successful kick-off meeting for the recruited ESRs, the training has officially started in the InPharma consortium. On the 1st and 2nd of September, a first “In-Pharma-tion” workshop was organized by Solvias, Roche and FHNW. The first day was focused on the formulation by introducing into industrial challenges and into a diverse range of computational tools. The second day had a more biopharmaceutical orientation and following an overview presentation on biopharmaceutical/developability classification and an introduction to special patient populations, different talks addressed physiologically-based pharmacokinetic (PBPK) modelling approaches in pharmaceutics. Excellent speakers were invited from inside as well as from outside of the consortium and the full agenda can be found online. The discussions were highly interesting and stimulating for all participants and there was certainly much to be learned for the different ESRs from this first successful “In-Pharma-tion” workshop.